Johnson & Johnson

Healthcare · Drug Manufacturers - General

270.20$ +1.1% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Johnson & Johnson (JNJ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 94,193 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement JNJ
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	21,620	22,629	23,995	28,007	29,172	32,317	36,298	41,862	47,348	50,514	53,324	61,095	63,747	61,897	61,587	65,030	67,224	71,312	74,331	70,074	71,890	76,450	81,581	82,059	82,584	78,740	79,990	85,159	88,821	94,193
Cost of Revenue	6,009	6,085	6,319	8,498	8,957	9,581	10,447	12,176	13,474	14,010	15,057	17,751	18,511	18,447	18,792	20,360	21,658	22,342	22,746	21,536	21,789	25,439	27,091	27,556	28,427	23,402	24,596	26,739	27,471	30,256
Gross Profit	15,611	16,544	17,676	19,509	20,215	22,736	25,851	29,686	33,874	36,504	38,267	43,344	45,236	43,450	42,795	44,670	45,566	48,970	51,585	48,538	50,101	51,011	54,490	54,503	54,157	55,338	55,394	58,413	61,350	63,937
Research & Development	1,905	2,140	2,336	2,768	3,105	3,591	3,957	4,684	5,344	6,462	7,125	7,680	7,577	6,986	6,844	7,548	7,665	8,183	8,494	9,046	9,143	10,594	10,775	11,355	12,340	14,277	14,135	15,048	17,232	14,665
Selling, General & Administrative	8,394	8,715	8,907	10,503	10,875	11,992	12,216	14,131	15,860	16,877	17,433	28,131	29,067	19,801	19,424	20,969	20,869	21,830	21,954	21,203	20,067	21,520	22,540	22,178	22,084	20,118	20,246	21,012	21,969	23,676
Total Operating Expenses	11,308	11,922	12,648	13,524	13,600	14,851	16,173	18,815	21,518	23,673	24,558	28,131	29,067	26,787	26,268	28,517	28,534	30,013	30,448	30,249	29,210	32,114	33,315	33,533	34,424	34,395	34,381	36,560	66,672	38,341
Operating Income	4,303	4,622	5,028	5,985	6,615	7,885	9,678	10,871	12,356	12,831	13,709	15,213	16,169	16,663	16,527	16,153	17,032	18,957	21,137	18,289	20,891	18,897	21,175	20,970	19,733	20,943	21,013	21,853	22,149	25,596
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	296	435	451	455	571	532	482	533	552	726	934	1,005	318	201	183	276	1,247	755	971
Pre-Tax Income	4,033	4,576	4,182	5,877	6,868	7,898	9,291	10,308	12,331	13,116	14,587	13,283	16,929	15,755	16,947	12,361	13,775	15,471	20,563	19,196	19,803	17,673	17,999	17,328	16,497	19,178	19,359	15,062	16,687	32,581
Income Tax Expense	1,146	1,273	1,179	1,604	1,915	2,230	2,694	3,111	4,151	3,056	3,534	2,707	3,980	3,489	3,613	2,689	3,261	1,640	4,240	3,787	3,263	16,373	2,702	2,209	1,783	1,377	2,989	1,736	2,621	5,777
Net Income	2,887	3,303	3,003	4,273	4,953	5,668	6,597	7,197	8,180	10,060	11,053	10,576	12,949	12,266	13,334	9,672	10,853	13,831	16,323	15,409	16,540	1,300	15,297	15,119	14,714	20,878	17,941	35,153	14,066	26,804
EBITDA	5,312	5,689	6,313	7,495	8,207	9,490	11,340	12,740	14,480	14,924	15,886	16,356	20,196	18,980	20,341	16,090	17,973	20,057	24,991	23,494	24,283	24,249	25,933	24,655	23,929	26,751	26,605	29,339	24,781	41,055

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings